HULL HANS (Chief Business Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/18/2023ACC: 0001209191-23-042658
Officer· Chief Business Officer
Since Jun 2020
+35.16K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
35.16K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35.16K
Price / share
—
Trade value
—
% of position
17.4%
7/14/2023
201.96K→237.12K
Total
Net shares
+35.16K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2023 | A · Award | +35.16K | — | — | 17.4% | 201.96K | 237.12K |
| Total | +35.16K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned3.82K
Total
31.79K indirect31.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.98K | Indirect |
| Common Stock | 13.98K | Indirect |
| Common Stock | 3.82K | Indirect |
| Total | 31.79K | 31.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported